Boston Scientific said Monday it will pay medical device rival Johnson and Johnson $1.73 billion to settle several seven-year-old patent disputes over drug-coated stents.
Boston Scientific Corp will pay $1.73 billion to Johnson and Johnson to settle three patent disputes involving heart stents that date back to 2003.
Boston Scientific Corp said on Monday it will pay $1.73 billion to Johnson and Johnson to settle three patent disputes involving heart stents that date back to 2003.
The agreement with Johnson and Johnson to settle three disputes involving heart stents is one of 17 that have been settled as Boston Scientific tries to clear up pending litigation.
Feb. 1 (Bloomberg) -- Boston Scientific Corp. will pay $1.73 billion to Johnson & Johnson?s Cordis unit to end patent- infringement claims over heart stents.
Under the terms of the deal, Boston Scientific will pay $1 billion to Johnson & Johnson on Monday, of which $800 million is in cash and $200 million is from borrowings under its credit facilities.
NEW YORK, Feb. 1 (UPI) -- U.S. healthcare giant Johnson & Johnson said it had reached a $1.7 billion settlement with Boston Scientific over patent violations for surgical stents.
Publick Theatre Boston's production of Joe Orton's Entertaining Mr. Sloane will begin previews March 11 at the Plaza Theatre with an official opening scheduled for March 14.
Feb. 1 (Bloomberg) -- Boston Scientific Corp. will pay $1.73 billion to Johnson & Johnson?s Cordis unit to end patent- infringement claims related to stents.
Boston Scientific Corp. agrees to pay rival Johnson & Johnson $1.725 billion to settle three additional patent disputes over their respective cardiac stent products.